Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Alphatec Holdings Inc (ATEC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: ATEC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit 25.43% | Avg. Invested days 44 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.51B USD | Price to earnings Ratio - | 1Y Target Price 18.04 |
Price to earnings Ratio - | 1Y Target Price 18.04 | ||
Volume (30-day avg) 2339098 | Beta 1.39 | 52 Weeks Range 4.88 - 14.54 | Updated Date 04/2/2025 |
52 Weeks Range 4.88 - 14.54 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -26.51% | Operating Margin (TTM) -11.83% |
Management Effectiveness
Return on Assets (TTM) -9.72% | Return on Equity (TTM) -291.71% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1924120258 | Price to Sales(TTM) 2.46 |
Enterprise Value 1924120258 | Price to Sales(TTM) 2.46 | ||
Enterprise Value to Revenue 3.15 | Enterprise Value to EBITDA -18.89 | Shares Outstanding 144148992 | Shares Floating 107283066 |
Shares Outstanding 144148992 | Shares Floating 107283066 | ||
Percent Insiders 25.18 | Percent Institutions 59.86 |
Analyst Ratings
Rating 4.42 | Target Price 16.88 | Buy 5 | Strong Buy 6 |
Buy 5 | Strong Buy 6 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Alphatec Holdings Inc
Company Overview
History and Background
Alphatec Holdings, Inc. was founded in 2006. It has grown through internal development and acquisitions to become a player in the spinal surgery market, focusing on innovation and procedural solutions.
Core Business Areas
- Spinal Implants and Instruments: Designs, develops, and markets a range of products for spinal fusion and other spinal procedures.
- Biologics: Offers biologic solutions used to promote spinal fusion.
- Software and Navigation: Develops and integrates software and navigation tools to enhance surgical precision and outcomes, including technologies like augmented reality navigation.
Leadership and Structure
The company is led by Patrick S. Miles, Chairman and CEO. The organizational structure includes departments for research and development, sales and marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- IdentiTi Porous TI Interbody Implant System: A line of porous titanium interbody implants designed to promote bone growth and spinal fusion. Competitors include Medtronic's TiONIC system, Stryker's Tritanium, and NuVasive's Modulus.
- EOS Imaging System: Enables full-body, weight-bearing imaging with reduced radiation exposure, used for diagnosis and surgical planning. Competitors include Siemens Healthineers and GE Healthcare in the broader imaging market.
- SafeOp Neural InformatiX System: System for minimizing risk of nerve damage during surgery. The SafeOp technology faces competition from Medtronic's NIM-ECLIPSE system and NuVasive's NVM5 system.
Market Dynamics
Industry Overview
The spinal device market is characterized by innovation in minimally invasive surgery, biologics, and navigation technologies. Aging populations and increasing demand for advanced surgical solutions drive growth. Increasing regulatory hurdles and pricing pressures affect profitability.
Positioning
Alphatec is positioned as a company focusing on innovation and procedural solutions. Its strategy involves developing technologies that improve surgical outcomes and efficiency. Alphatec is seeking to take market share from the established leaders in the spinal device market.
Total Addressable Market (TAM)
The global spine surgery market is estimated to be around $10 billion. Alphatec is aiming to expand its market share within this large market through its focus on innovation and expanding its product portfolio.
Upturn SWOT Analysis
Strengths
- Innovative product portfolio
- Strong focus on technology development
- Experienced leadership team
- Growing sales force
Weaknesses
- Smaller market share compared to major competitors
- Limited profitability history
- High operating expenses
- Reliance on key products
Opportunities
- Expanding into new geographical markets
- Developing new strategic partnerships
- Capitalizing on the aging population trend
- Increasing adoption of minimally invasive surgery
Threats
- Intense competition from larger companies
- Pricing pressures from hospitals and insurers
- Regulatory changes
- Product liability risks
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- BSX
- NUVA
- ZBH
Competitive Landscape
Alphatec is a smaller player compared to its main competitors. Alphatec differentiates itself through its focus on technology and innovative solutions, but it needs to continue gaining market share to achieve sustainable profitability.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Alphatec has demonstrated growth in recent years, driven by product innovation and expanding sales efforts. However, the company has struggled to achieve consistent profitability.
Future Projections: Analyst projections for Alphatec's future growth vary, but generally anticipate continued revenue growth driven by new product launches and market expansion. Profitability remains a key area of focus for investors.
Recent Initiatives: Recent initiatives include the launch of new spinal implant systems, expanding its sales force, and investing in software and navigation technologies.
Summary
Alphatec is an innovative player in the spinal surgery market with a growing portfolio of products. However, the company is smaller than its competitors and has not yet achieved consistent profitability. Alphatec needs to continue to innovate and grow its market share to become a sustainable and successful company. It needs to carefully manage its operating expenses and navigate the competitive landscape.
Similar Companies
BSX
Boston Scientific Corp
BSX
Boston Scientific Corp
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SIFI
Harbor Scientific Alpha Income
SIFI
Harbor Scientific Alpha Income
ZBH
Zimmer Biomet Holdings Inc
ZBH
Zimmer Biomet Holdings Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alphatec Holdings Inc
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 2006-06-02 | Executive Chairman, CEO & President Mr. Patrick S. Miles | ||
Sector Healthcare | Industry Medical Devices | Full time employees 867 | Website https://www.atecspine.com |
Full time employees 867 | Website https://www.atecspine.com | ||
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.